O6-methylguanine-DNA methyltransferase gene (MGMT) expression in human glioblastomas in relation to patient characteristics and p53 accumulation

International Journal of Cancer

Volumn 84, Issue 4, 1999, Pages 416-420

  Rolhion, Christine ^a,b   Penault Llorca, Frédérique ^a   Kemeny, Jean Louis ^c   Kwiatkowski, Fabrice ^a   Lemaire, Jean Jacques ^d   Chollet, Philippe ^a,b   Finat Duclos, Françoise ^a   Verrelle, Pierre ^a  

^a CENTRE JEAN PERRIN   (France)

^b INSERM   (France)

^c SERVICE DE RHUMATOLOGIE   (France)

^d Hopital Fontmaure   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROETHYLNITROSOUREA; DNA METHYLTRANSFERASE; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER RESISTANCE; CORRELATION FUNCTION; DISEASE CLASSIFICATION; FEMALE; GENE EXPRESSION SYSTEM; GLIOBLASTOMA; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CARMUSTINE; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; GLIOMA; HUMANS; MALE; MIDDLE AGED; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECURRENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEX FACTORS; SURVIVAL ANALYSIS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032772685     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990820)84:4<416::AID-IJC15>3.0.CO;2-A     Document Type: Article

References (21)

1. 6-methylguanine DNA methyltransferase protects Chinese hamster ovary from spontaneous G:C to A:T transitions. Cancer Res., 52, 6471-6475 (1992).
2. BARBARESCHI, M., Prognostic value of the immunohistochemical expression of p53 in breast carcinomas. A review of the literature involving over 9,000 patients. Appl. Immunohistochem., 4, 106-116 (1996).
3. BELANICH, M. AND 17 OTHERS, Retrospective study of the correlation between the DNA repair protein alkyltransferase and survival of brain tumor patients treated with carmustine. Cancer Res., 56, 783-788 (1996).
4. BÖGLER, O., HUANG, H.-J.S., KLEIHUES, P. and CAVENNEE, W.K., The p53 gene and its role in human brain tumors. Glia, 15, 308-327 (1995).
5. FINE, H.A., DEAR, K.B.G., LOEFFLER, J.S., BLACK, P.M. and CANELLOS, G.P., Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer, 71, 2585-2597 (1993).
6. FULCI, G., ISHII, N. and VAN MEIR, E.G., p53 and brain tumors: from gene mutations to gene therapy. Brain Pathol., 8, 599-613 (1998).
7. 6-Amethylguanine-DNA methyltransferase gene. Cancer Res., 56, 2029-2032 (1996).
8. 6-methylguanine-DNA-methlytransferase levels with survival of malignant astrocytoma patients treated with bis-chloroethylnitrosourea: a Southwest Oncology Group study. J. clin. Oncol., 16, 3310-3315 (1998).
9. KORKOLOPOULOU, P., CHRISTODOULOU, P., KOUZELIS, K., HADJlYANNAKlS, M., PRIFTIS, A., STAMOULIS, G., SERETIS, A. and THOMAS-TSAGLI, E., MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor. Brit. J. Cancer, 75, 1269-1278 (1997).
10. LEENSTRA, S., OSKAM, N.T., BIJLEVELD, E.H., BOSCH, D.A., TROOST, D. and HULSEBOS, T.J.M., Genetic sub-types of human malignant astrocytoma correlates with survival. Int. J. Cancer (Pred. Oncol.), 79, 159-165 (1998).
11. 6-methylguanine DNA methyltransferase mRNA and its significance as an indicator of selective chloroethylnitrosourea chemotherapy. Int. J. Cancer (Pred. Oncol.), 69, 420-425 (1996).
12. NEWCOMB, E.W., COHEN, H., LEE, S.R., BHALLA, S.K., BLOOM, J., HAYES, R.L. and MILLER, D.C., Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes. Brain Pathol., 8, 655-667 (1998).
13. 6-methylguanine-DNA methyltransferase expression. Pharmacol. Ther., 74, 285-297 (1997).
14. 6-alkylguanine DNA alkyltransferase in response to ionising radiation is p53 gene dose dependent. Oncogene, 12, 693-697 (1996).
15. RASHEED, A.B.K., MCLENDON, R.E., HERNDON, I.E., FRIEDMAN, H.S., FRIEDMAN, A.H., BIGNER, D.D. and BIGNER, S.H., Alterations of the Tp53 gene in human gliomas. Cancer Res., 54, 1324-1330 (1994).
16. 6-alkylguanine DNA alkyltransferase activity, and sensitivity to procarbazine in human brain tumors. Cancer, 75, 1339-1342 (1995).
17. 6-methylguanine-DNA methyltransferase activity in adult gliomas: relation to patient and tumor characteristics. Cancer Res., 58, 1068-1073 (1998).
18. 6-methylguanine DNA methyltransferase activity in brain tumor and adjacent normal brain. Cancer Res., 53, 3416-3420 (1993).
19. TADA, M., MATSUMOTO, R., IGGO, R.D., ONIMARU, R., SHIRATO, H., SAWAMURA, Y. and SHINOHE, Y., Selective sensitivity to radiation of cerebral glioblastomas harboring p53 mutations. Cancer Res., 58, 1793-1797 (1998).
20. WEI, Q., MATANOSKI, G.M., FARMER, E.R., HEDAYATI, M.A. and GROSSMAN, L., DNA repair and aging in basal cell carcinoma: a molecular epidemiology study. Proc. nat. Acad. Sci. (Wash.), 90, 1614-1618 (1993).
21. WELLER, M., Predicting response to cancer chemotherapy: the role of p53. Cell Tissue Res., 292, 435-445 (1998).